Childhood non-hodgkin's lymphoma: Long-term results of an intensive chemotherapy regimen
โ Scribed by Marco Gasparini; Fabrizio Lombardi; Franca Fossati Bellani; Cristina Gianni; Silvana Pilotti; Franco Rilke
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 426 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This study compared the resting energy expenditure (REE) modifications observed during successive intensive identical chemotherapy courses in non-Hodgkin's lymphoma patients to assess indirectly the metabolic changes induced by the cytotoxic effect of drugs on the tumor. With this therapeutic regime
## Abstract It is well documented that cytotoxic treatment in patients carrying the hepatitis B virus (HBV) enhances the risk of severe hepatic damage. Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions. Here we report two cases with HB
Background. Cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COP-BLAM-I) is a second generation combination chemotherapy for intermediate-grade non-Hodgkin's lymphoma (NHL). Since the first report by Laurence et al. in 1982, only a few series were reported on the
## Background: The aim of this study was to determine the long term outcome and toxicities after the administration of 2-chlorodeoxyadenosine (2-cda) to patients with previously treated, advanced, indolent non-hodgkin's lymphoma (nhl). ## Methods: Twenty-two patients (median age, 55 years) with r
Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as